Enliven Therapeutics Inc. Earnings

The next earnings date for Enliven Therapeutics Inc. has not yet been scheduled.

Analyst Estimates of Enliven Therapeutics Inc. Earnings

No Results.

Report Date	Estimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Enliven Therapeutics Inc. Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
03/12/2026	---	$-0.48	-27.05%
11/06/2025	---	$0	100.00%
08/07/2025	---	$0	100.00%
05/12/2025	Before Market	$-0.57	-13.03%
03/12/2025	Before Market	$-0.46	11.11%
11/07/2024	Before Market	$-0.48	4.36%
08/13/2024	After Market	$-0.41	25.45%
05/14/2024	After Market	$-0.54	5.26%
03/14/2024	After Market	$-0.47	12.96%
11/09/2023	After Market	$-0.51	-8.51%
08/10/2023	After Market	$-0.41	-13.89%
05/11/2023	After Market	$-0.80	-26.98%
02/10/2023	After Market	$1.21	253.94%
10/25/2022	After Market	$-0.72	28.00%
08/03/2022	After Market	$-1.76	14.15%
05/06/2022	Before Market	$-2.24	3.03%
03/15/2022	Before Market	$-2.12	29.33%
11/09/2021	Before Market	$-2.20	34.91%
08/06/2021	Before Market	$-2.96	7.50%
05/11/2021	Before Market	$-2.32	30.54%
03/05/2021	Before Market	$-2.24	33.13%
11/05/2020	Before Market	$-2.88	10.28%
08/14/2020	Before Market	$-2.36	-4.89%
05/07/2020	Before Market	$-17.24	-486.39%
03/11/2020	After Market	$-0.68	---
10/08/2019	---	$-0.32	---

More About Enliven Therapeutics Inc.

Website

https://www.enliventherapeutics.com

Country

USA

Full Time Employees

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its clinical programs comprise ELVN-001, a small molecule kinase inhibitor which is in Phase 1 clinical trial to treat adults with chronic myeloid leukemia; and ELVN-002, a central nervous system (CNS) penetrant and irreversible human epidermal growth factor receptor 2 inhibitor that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer (NSCLC) and other HER2 mutant tumors. The company was founded in 2019 and is headquartered in Boulder, Colorado.

“Enliven Therapeutics Inc. Earnings” Can Refer to the Enliven Therapeutics Inc. Earnings Date

Some people say “Enliven Therapeutics Inc. earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Enliven Therapeutics Inc. position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Enliven Therapeutics Inc. Stock on the Earnings Date

If you own Enliven Therapeutics Inc. stock (ELVN) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Enliven Therapeutics Inc. might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Enliven Therapeutics Inc. shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Enliven Therapeutics Inc. Earnings

You can contact us any time if you would like to ask questions about Enliven Therapeutics Inc. earnings or anything else related to the stock market.